As of November 6, 2026, Ponce Financial Group, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on March 31, 2026, naming 1 appointment. The latest filing names Marlene Cintron, appointed (Form 8-K, March 31, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Ponce Financial Group, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Ponce Financial Group, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-03-31. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Ponce Financial Group, Inc. files it.
Also on the record for Ponce Financial Group, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| May 7, 2026 | Stake report, Schedule 13G/A, by Ponce Bank Employees Stock Ownership Plan with 401(k) Provisions; Pentegra Trust Company, Trustee | 7.7% of the class | 5%+ stakes | Source |
| February 17, 2026 | Stake report, Schedule 13G/A, by T. Rowe Price Investment Management, Inc. | 7.9% of the class | 5%+ stakes | Source |
| February 4, 2026 | Stake report, Schedule 13G/A, by M3 Funds, LLC | 7.73% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Ponce Financial Group, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Ponce Financial Group, Inc. and the records around it.
Ponce Financial Group, Inc. elsewhere on the record
- 5%+ stake filings May 2026
- Who owns it
Companies that share a holder
- M3 Funds, LLC also filed stake reports on 12 other companies: AerSale Corp. (Oct 2026), FIRST NORTHERN COMMUNITY BANCORP (Aug 2026), BANKFINANCIAL CORP (Feb 2026)
- T. Rowe Price Investment Management, Inc. also filed stake reports on 167 other companies: CABALETTA BIO INC (Nov 2026), MADISON SQUARE GARDEN SPORTS CORP (Nov 2026), MSG RANGERS CORP (Nov 2026)
Watch Ponce Financial Group, Inc.
Get an email when Ponce Financial Group, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Ponce Financial Group, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Ponce Financial Group, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Ponce Financial Group, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
4 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-03-31 | In | 8-K, 2026-03-31 |
New leaders reset buying decisions — get the Full Report on Ponce Financial Group, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at Ponce Financial Group, Inc., with the record behind each one.
Find candidates like senior executive at Ponce Financial Group, Inc.Every change, in the filing's words
Appointed: Marlene Cintron
On March 26, 2026, the Board of Directors (the "Board") of Ponce Financial Group, Inc., (the "Company"), the holding company for Ponce Bank, N.A. (the "Bank"), appointed Ms. Marlene Cintron to the Board effective immediately.
- Ms. Cintron will serve until the Company's annual meeting of shareholders in 2026, at which time it is contemplated that she will be a nominee for election to a three-year term ending at the annual meeting of shareholders in 2029 or until her successor is elected and qualified.
- Ms. Cintron will also be appointed to the Audit Committee and the Executive Compensation Committee of the Company's Board of Directors.
- These loans were made in the ordinary course of business, made on substantially the same terms, including interest rates and collateral, as those prevailing at the time for comparable loans with persons not related to Ponce Bank and for which management believes neither involve more than the normal risk of collection nor present other unfavorable features.
- As a non-employee director, Ms. Cintron will receive the Company's standard Board compensation, which currently consists of an annual fee of $48,000 per year and fees of $500 per meeting for service on the committees of the Board.
- Ms. Cintron is also eligible to receive restricted stock or option grants pursuant to the Company's 2023 Long-Term Incentive Plan from time to time as determined by the Board.
Tools for this story
Each opens in a new tab, filled in for Ponce Financial Group, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.